NASDAQ: MGXMetagenomi Inc Stock Ownership - Who owns Metagenomi?
Insider buying vs selling
Have Metagenomi Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jian Irish | Title President and Chief Operating Officer | 2025-06-06 | 6,390 | $1.75 | $11.18kSell |
| Sarah B. Noonberg | Chief Medical Officer | 2025-06-06 | 5,239 | $1.75 | $9.17kSell |
| Brian C. Thomas | Chief Executive Officer | 2025-06-06 | 10,785 | $1.75 | $18.87kSell |
| Pamela Wapnick | Chief Financial Officer | 2025-06-06 | 1,576 | $1.75 | $2.76kSell |
| Matthew Wein | Officer | 2025-06-06 | 199 | $1.75 | $348.25Sell |
| Matthew Wein | Officer | 2025-03-05 | 930 | $1.88 | $1.74kSell |
| Pamela Wapnick | Chief Financial Officer | 2025-03-05 | 1,808 | $1.88 | $3.39kSell |
| Pamela Wapnick | Chief Financial Officer | 2024-12-05 | 1,559 | $1.86 | $2.90kSell |
MGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MGX insiders and whales buy or sell their stock.
MGX Shareholders
What type of owners hold Metagenomi Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bayer Healthcare LLC | 10.79% | 4,050,997 | $10.29M | Insider |
| Sebastian Bernales | 8.18% | 3,068,786 | $7.79M | Insider |
| Brian C. Thomas | 6.71% | 2,517,491 | $6.39M | Insider |
| Holdings A. Novo | 4.63% | 1,739,175 | $4.42M | Insider |
| Vanguard Group Inc | 3.35% | 1,257,639 | $3.19M | Institution |
| Pura Vida Investments LLC | 2.54% | 952,134 | $2.42M | Institution |
| Sozo Ventures GP II LP | 1.55% | 581,577 | $1.48M | Institution |
| Catalio Capital Management LP | 1.41% | 528,993 | $1.34M | Institution |
| Peapod Lane Capital LLC | 1.35% | 508,109 | $1.29M | Institution |
| Jian Irish | 1.32% | 494,025 | $1.25M | Insider |
MGX vs Biotech Stocks
Metagenomi Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.